$KPTI
Karyopharm Therapeutics Inc.

2016 Q3 Form 10-Q Financial Statement

#000119312516671775 Filed on August 04, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2016 Q2 2015 Q2
Revenue $48.00K $59.00K $150.0K
YoY Change -36.0% -60.67% 614.29%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.900M $5.960M $6.160M
YoY Change 23.95% -3.25% 86.1%
% of Gross Profit
Research & Development $19.89M $24.58M $27.01M
YoY Change -23.26% -8.99% 105.23%
% of Gross Profit
Depreciation & Amortization $180.0K $180.0K $150.0K
YoY Change 5.88% 20.0% 200.0%
% of Gross Profit
Operating Expenses $25.79M $30.54M $33.16M
YoY Change -15.95% -7.92% 101.37%
Operating Profit -$25.74M -$30.48M -$33.01M
YoY Change -15.9% -7.68% 100.71%
Interest Expense $310.0K $330.0K $270.0K
YoY Change 29.17% 22.22% 1250.0%
% of Operating Profit
Other Income/Expense, Net $317.0K $318.0K $318.0K
YoY Change 33.76% 0.0% 1770.59%
Pretax Income -$25.43M -$30.16M -$32.70M
YoY Change -16.28% -7.77% 99.03%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$25.43M -$30.16M -$32.70M
YoY Change -16.29% -7.76% 98.98%
Net Earnings / Revenue -52968.75% -51115.25% -21796.67%
Basic Earnings Per Share
Diluted Earnings Per Share -$690.7K -$838.7K -$916.0K
COMMON SHARES
Basic Shares Outstanding 35.99M shares 35.96M shares 35.69M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q3 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $126.8M $122.7M $221.2M
YoY Change -35.04% -44.53% 67.2%
Cash & Equivalents $43.91M $37.72M $24.23M
Short-Term Investments $82.90M $85.00M $197.0M
Other Short-Term Assets $3.400M $1.500M $4.100M
YoY Change 9.68% -63.41% 36.67%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $130.3M $124.2M $225.3M
YoY Change -34.33% -44.86% 66.5%
LONG-TERM ASSETS
Property, Plant & Equipment $2.991M $3.170M $3.234M
YoY Change -18.28% -1.98% 435.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $49.60M $42.90M $34.40M
YoY Change 44.19% 24.71%
Other Assets $299.0K $111.0K $400.0K
YoY Change 475.0% -72.25% -71.26%
Total Long-Term Assets $53.37M $46.70M $38.04M
YoY Change 38.17% 22.75% 1487.69%
TOTAL ASSETS
Total Short-Term Assets $130.3M $124.2M $225.3M
Total Long-Term Assets $53.37M $46.70M $38.04M
Total Assets $183.6M $170.9M $263.3M
YoY Change -22.51% -35.09% 91.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.193M $4.063M $4.469M
YoY Change -51.99% -9.08% 29.31%
Accrued Expenses $12.31M $11.11M $9.333M
YoY Change 29.99% 19.06% 365.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.95M $15.52M $14.10M
YoY Change 3.55% 10.1% 149.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.700M $1.800M $1.900M
YoY Change -10.53% -5.26% 1158.28%
Total Long-Term Liabilities $1.700M $1.800M $1.900M
YoY Change -10.53% -5.26% 1158.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.95M $15.52M $14.10M
Total Long-Term Liabilities $1.700M $1.800M $1.900M
Total Liabilities $16.69M $17.33M $15.97M
YoY Change 1.9% 8.55% 166.14%
SHAREHOLDERS EQUITY
Retained Earnings -$339.2M -$313.7M -$197.1M
YoY Change 49.1% 59.17%
Common Stock $506.1M $467.2M $444.6M
YoY Change 12.95% 5.08% 14819166.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $166.9M $153.6M $247.3M
YoY Change
Total Liabilities & Shareholders Equity $183.6M $170.9M $263.3M
YoY Change -22.51% -35.09% 91.24%

Cashflow Statement

Concept 2016 Q3 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income -$25.43M -$30.16M -$32.70M
YoY Change -16.29% -7.76% 98.98%
Depreciation, Depletion And Amortization $180.0K $180.0K $150.0K
YoY Change 5.88% 20.0% 200.0%
Cash From Operating Activities -$20.33M -$20.89M -$28.09M
YoY Change -19.74% -25.63% 136.45%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.00K -$590.0K
YoY Change -100.0% -98.31% 84.38%
Acquisitions
YoY Change
Other Investing Activities -$4.970M $16.22M $1.450M
YoY Change -111.12% 1018.62%
Cash From Investing Activities -$4.980M $16.22M $860.0K
YoY Change -111.18% 1786.05% -368.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 31.48M 240.0K 20.00K
YoY Change 78600.0% 1100.0% -105.26%
NET CHANGE
Cash From Operating Activities -20.33M -20.89M -28.09M
Cash From Investing Activities -4.980M 16.22M 860.0K
Cash From Financing Activities 31.48M 240.0K 20.00K
Net Change In Cash 6.170M -4.430M -27.21M
YoY Change -67.96% -83.72% 116.3%
FREE CASH FLOW
Cash From Operating Activities -$20.33M -$20.89M -$28.09M
Capital Expenditures $0.00 -$10.00K -$590.0K
Free Cash Flow -$20.33M -$20.88M -$27.50M
YoY Change -19.29% -24.07% 137.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24231000
CY2016Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
462000
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
138000
CY2016Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
127952000
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11112000
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
79000
CY2014Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
3681 sqft
CY2014Q4 kpti Operating Lease Scheduled Rent Payments Due
OperatingLeaseScheduledRentPaymentsDue
374000
CY2014Q4 kpti Operating Lease Scheduled Rent Payments Due
OperatingLeaseScheduledRentPaymentsDue
414000
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35989260 shares
CY2014Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
29933 sqft
CY2014Q1 us-gaap Security Deposit
SecurityDeposit
400000
CY2014Q1 kpti Estimated Future Security Deposit
EstimatedFutureSecurityDeposit
200000
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2099000
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
155165000
CY2016Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
12000
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1486000
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35989260 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35989260 shares
CY2016Q2 us-gaap Assets
Assets
170897000
CY2016Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
229000
CY2016Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1808000
CY2016Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
269000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
124200000
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
467168000
CY2016Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
127735000
CY2016Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
25406000
CY2016Q2 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
0 Securities
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37717000
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
4000
CY2016Q2 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
19 Securities
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4063000
CY2016Q2 us-gaap Liabilities
Liabilities
17331000
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
170897000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
15523000
CY2016Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
358000
CY2016Q2 us-gaap Long Term Investments
LongTermInvestments
42933000
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
111000
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3170000
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4656000
CY2016Q2 us-gaap Short Term Investments
ShortTermInvestments
85019000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
153566000
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-313744000
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1464000
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
483000
CY2016Q2 kpti Additional Area Included In Operating Sublease After Amendment
AdditionalAreaIncludedInOperatingSubleaseAfterAmendment
16234 sqft
CY2016Q2 kpti Operating Lease Property Leased Area Covered Under Amended Agreement
OperatingLeasePropertyLeasedAreaCoveredUnderAmendedAgreement
27701 sqft
CY2016Q2 kpti Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
8193000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
150609000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2445000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
200325000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
215000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1128000
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35864765 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35864765 shares
CY2015Q4 us-gaap Assets
Assets
215443000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
26000
CY2015Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1946000
CY2015Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
206000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
177600000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
455170000
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
151342000
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
117851000
CY2015Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
0 Securities
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58358000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2015Q4 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
69 Securities
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3808000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
270000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-282000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
151153000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11023000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15132000
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
95000
CY2015Q4 us-gaap Liabilities
Liabilities
17078000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
215443000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
301000
CY2015Q4 us-gaap Long Term Investments
LongTermInvestments
33878000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3483000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4611000
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
117275000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
198365000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-256527000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1967000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
482000
CY2015Q4 kpti Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
8007000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-816000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-126378000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.65
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11556000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-9000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
292000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58877000
us-gaap Sales Revenue Net
SalesRevenueNet
150000
us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
-699000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
464000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
401000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
209517000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3446000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
347000
us-gaap Operating Expenses
OperatingExpenses
59313000
us-gaap Net Income Loss
NetIncomeLoss
-58762000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-169222000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
41069000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-73000
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
52000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1782000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2038000
us-gaap Operating Income Loss
OperatingIncomeLoss
-59163000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
91177000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-42000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
774000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-774000
us-gaap Investment Income Interest
InvestmentIncomeInterest
408000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-48324000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47757000
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
5403 shares
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
125000
us-gaap Share Based Compensation
ShareBasedCompensation
8231000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35508146 shares
kpti Restricted Shares Common Stock Vested Value
RestrictedSharesCommonStockVestedValue
84000
kpti Proceeds From Payments For Common Stock Issuance Net
ProceedsFromPaymentsForCommonStockIssuanceNet
90830000
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
22000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-595000
dei Entity Registrant Name
EntityRegistrantName
KARYOPHARM THERAPEUTICS INC.
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001503802
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-20641000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.59
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11510000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
14000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
358000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-56797000
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Sales Revenue Net
SalesRevenueNet
59000
us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
75000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
579000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
608000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
87033000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
70000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
436000
us-gaap Net Income Loss
NetIncomeLoss
-57217000
us-gaap Operating Expenses
OperatingExpenses
57884000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
436000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
407000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
89000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
22968000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
110046000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
233000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-503000
us-gaap Operating Income Loss
OperatingIncomeLoss
-57825000
us-gaap Investment Income Interest
InvestmentIncomeInterest
615000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-44059000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45000
dei Trading Symbol
TradingSymbol
KPTI
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46374000
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
29724 shares
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
235000
us-gaap Share Based Compensation
ShareBasedCompensation
11563000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35917486 shares
kpti Operating Leases Allowance For Improvements
OperatingLeasesAllowanceForImprovements
1616000
CY2014Q4 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P5Y
CY2014Q1 kpti Number Of Additional Lease Terms Option To Renew
NumberOfAdditionalLeaseTermsOptionToRenew
1 Lease
CY2014Q1 kpti Lessee Leasing Arrangements Operating Leases Additional Extension Term
LesseeLeasingArrangementsOperatingLeasesAdditionalExtensionTerm
P5Y
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.92
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6157000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32857000
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
150000
CY2015Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
240000
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
318000
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
51000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
33163000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-32695000
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-68000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-33013000
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-94000
CY2015Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
267000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27006000
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35697012 shares
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.84
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5956000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30114000
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
59000
CY2016Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
290000
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
318000
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
30535000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-30158000
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-20000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-30476000
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
64000
CY2016Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
329000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24579000
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35956470 shares

Files In Submission

Name View Source Status
0001193125-16-671775-index-headers.html Edgar Link pending
0001193125-16-671775-index.html Edgar Link pending
0001193125-16-671775.txt Edgar Link pending
0001193125-16-671775-xbrl.zip Edgar Link pending
d201290d10q.htm Edgar Link pending
d201290dex311.htm Edgar Link pending
d201290dex312.htm Edgar Link pending
d201290dex321.htm Edgar Link pending
d201290dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kpti-20160630.xml Edgar Link completed
kpti-20160630.xsd Edgar Link pending
kpti-20160630_cal.xml Edgar Link unprocessable
kpti-20160630_def.xml Edgar Link unprocessable
kpti-20160630_lab.xml Edgar Link unprocessable
kpti-20160630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending